HC Wainwright Forecasts Strong Price Appreciation for Nuvation Bio (NYSE:NUVB) Stock
Nuvation Bio (NYSE:NUVB – Free Report) had its price objective upped by HC Wainwright from $10.00 to $11.00 in a research ...
What is HC Wainwright’s Forecast for MNPR FY2026 Earnings?
Research analysts at HC Wainwright upped their FY2026 earnings estimates for Monopar Therapeutics in a report issued on Wednesday, January 22nd. HC Wainwright analyst S. Lee now expects that the ...
H.C. Wainwright cuts ALX Oncology target to $5, keeps buy rating
H.C. Wainwright analysts have reduced the price target for ALX Oncology (NASDAQ:ALXO) shares to $5 from the previous $25 ...
Lexaria Bioscience stock target cut to $7 at H.C. Wainwright
H.C. Wainwright adjusted its price target for Lexaria Bioscience (NASDAQ:LEXX) to $7.00, down from the previous target of $10.00, while maintaining a Buy rating on the company's shares. With the stock ...
LSI Industries price target raised to $30 from $20 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on LSI Industries (LYTS) to $30 from $20 and keeps a Buy rating on the shares. The firm cites ...
Eton Pharmaceuticals price target raised to $33 from $17 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth raised the firm’s price target on Eton Pharmaceuticals (ETON) to $33 from $17 and keeps a Buy ...
Nasdaq17d
H.C. Wainwright cuts Jasper target, says 50% selloff overdone
H.C. Wainwright lowered the firm’s price target on Jasper Therapeutics (JSPR) to $40 from $60 and keeps a Buy rating on the shares after the company announced initial data from the BEACON study ...
Seeking Alpha23d
Corvus wins new buy from H.C. Wainwright despite recent selloff
H.C. Wainwright launched its coverage of eczema drug developer Corvus Pharmaceuticals (NASDAQ:CRVS) with a Buy recommendation and an $11 per share target on Thursday, despite an over 38% drop ...
bovnews3d
Why Did H.C. Wainwright Give Immunic Inc (IMUX) Stock Buy Rating?
Immunic Inc (IMUX) stock saw a modest uptick, ending the day at $0.95 which represents no change from the prior close of of $0.95. The stock opened at $0.98 and touched a low of $0.92 during the day, ...
Nasdaq26d
MetaVia initiated with a Buy at H.C. Wainwright
H.C. Wainwright initiated coverage of MetaVia (MTVA) with a Buy rating and $12 price target The company’s DA-1726 is a novel oxyntomodulin analogue designed as a dual agonist targeting glucagon ...
cryptopolitan4d
BTCS Inc. to Participate in Fireside Chat with Blockdaemon hosted by H.C. Wainwright
BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a leader in blockchain infrastructure and technology, has announced its ...
Yahoo Finance1mon
Palvella Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright initiated coverage of Palvella Therapeutics (PVLA) with a Buy rating and $38 price target Palvella’s lead product, QTORIN 3.9% rapamycin anhydrous gel, is currently in ...